Vaseva et al. have recently found that the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17AAG) induces cancer cell apoptosis and synergistically enhances nutlin-3-induced apoptosis in a p53-dependent manner (113). Here, TP53 is linked to cancer.